Porous ureteral stent
    1.
    发明授权
    Porous ureteral stent 有权
    多孔输尿管支架

    公开(公告)号:US08740989B2

    公开(公告)日:2014-06-03

    申请号:US13488075

    申请日:2012-06-04

    Abstract: In some embodiments, a stent includes an elongate member and a distal retention member. The elongate member is configured to be disposed within a ureter of a patient and has a first portion, a second portion and a plurality of beads bonded together. The plurality of beads define a plurality of spaces between the plurality of beads. The plurality of spaces are configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member. The distal retention member is configured to help maintain a portion of the stent within a kidney of the patient.

    Abstract translation: 在一些实施例中,支架包括细长构件和远侧保持构件。 细长构件被配置为设置在患者的输尿管内,并且具有结合在一起的第一部分,第二部分和多个珠。 多个珠在多个珠之间限定多个空间。 多个空间被配置为允许流体从细长构件的第一部分流动到细长构件的第二部分。 远端定位构件构造成帮助将支架的一部分维持在患者的肾脏内。

    IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY
    2.
    发明申请
    IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY 失效
    用于控制药物递送的可植入或不可剥离的医疗装置

    公开(公告)号:US20120150096A1

    公开(公告)日:2012-06-14

    申请号:US13404832

    申请日:2012-02-24

    Abstract: Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.

    Abstract translation: 提供可植入或可插入的医疗装置,其包括:(a)生物相容性聚合物; 和(b)选自抗炎剂,止痛剂,麻醉剂和解痉药的至少一种治疗剂。 医疗装置适于在植入或插入时与疼痛或不适相关的部位植入或插入。 在许多实施方案中,治疗剂将选自(i)酮咯酸及其药学上可接受的盐(例如酮咯酸氨丁三醇)和(ii)4-二乙基氨基-2-丁炔基苯基环己基乙醇酸酯及其药学上可接受的盐(例如,奥昔布宁 氯化物)。 还提供了用于可植入或可插入的医疗装置的用途,其使用包括减少伴随这种装置的植入或插入的疼痛或不适。 进一步的用途可以包括减少沿着装置的微生物累积。 还提供了用于制造植入式或可插入医疗装置的方法。

    OCCLUSION OF FALLOPIAN TUBES IN A VERTEBRATE SUBJECT
    3.
    发明申请
    OCCLUSION OF FALLOPIAN TUBES IN A VERTEBRATE SUBJECT 有权
    在一个VERTEBRATE主题中的FALLOPIAN管的声明

    公开(公告)号:US20100294282A1

    公开(公告)日:2010-11-25

    申请号:US12782958

    申请日:2010-05-19

    CPC classification number: A61F6/225

    Abstract: According to one claim of the invention, a method for occluding a fallopian tube in a vertebrate subject is described, which comprises comprising transcervically delivering a solid blocking material into the fallopian tube. In various embodiments, a fluid sealing material is delivered along with the solid blocking material. Other claims of the invention pertain to articles of manufacture, delivery devices and kits for use in occluding the fallopian tubes of a vertebrate subject.

    Abstract translation: 根据本发明的一个权利要求,描述了一种用于在脊椎动物受试者中闭塞输卵管的方法,其包括将固体阻塞材料递送到输卵管中。 在各种实施例中,流体密封材料与固体阻挡材料一起被输送。 本发明的其它权利要求涉及用于阻塞脊椎动物对象的输卵管的制品,递送装置和试剂盒。

    Surgical composite barbed suture
    5.
    发明授权
    Surgical composite barbed suture 有权
    手术复合带刺缝合

    公开(公告)号:US09011489B2

    公开(公告)日:2015-04-21

    申请号:US12394965

    申请日:2009-02-27

    Abstract: In one embodiment, a medical device includes an elongate member configured to be inserted into a body. The elongate member has a first end portion and a second end portion opposite the first end portion. The elongate member includes a retaining member extending from the elongate member. The retaining member is configured to anchor the elongate member with respect to bodily tissue. The first end portion of the elongate member includes a coupling portion configured to be coupled to a filament. The second end portion of the elongate member includes a coupling portion configured to be coupled to the filament.

    Abstract translation: 在一个实施例中,医疗装置包括构造成插入到身体中的细​​长构件。 细长构件具有第一端部和与第一端部相对的第二端部。 细长构件包括从细长构件延伸的保持构件。 保持构件构造成相对于身体组织锚定细长构件。 细长构件的第一端部包括被配置为联接到细丝的联接部分。 细长构件的第二端部包括被配置为联接到细丝的联接部分。

    Implantable or insertable medical devices for controlled drug delivery
    6.
    发明授权
    Implantable or insertable medical devices for controlled drug delivery 失效
    用于受控药物递送的可植入或可插入的医疗装置

    公开(公告)号:US08691264B2

    公开(公告)日:2014-04-08

    申请号:US13404832

    申请日:2012-02-24

    Abstract: Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.

    Abstract translation: 提供可植入或可插入的医疗装置,其包括:(a)生物相容性聚合物; 和(b)选自抗炎剂,止痛剂,麻醉剂和解痉药的至少一种治疗剂。 医疗装置适于在植入或插入时与疼痛或不适相关的部位植入或插入。 在许多实施方案中,治疗剂将选自(i)酮咯酸及其药学上可接受的盐(例如酮咯酸氨丁三醇)和(ii)4-二乙基氨基-2-丁炔基苯基环己基乙醇酸酯及其药学上可接受的盐(例如,奥昔布宁 氯化物)。 还提供了用于可植入或可插入的医疗装置的用途,其使用包括减少伴随这种装置的植入或插入的疼痛或不适。 进一步的用途可以包括减少沿着装置的微生物累积。 还提供了用于制造植入式或可插入医疗装置的方法。

    Ureteral Stent
    8.
    发明申请
    Ureteral Stent 有权
    输尿管支架

    公开(公告)号:US20100160848A1

    公开(公告)日:2010-06-24

    申请号:US12635345

    申请日:2009-12-10

    Abstract: In some embodiments, a ureteral stent includes an elongate member having a first portion and a second portion, which is coupled to the first portion. The first portion of the elongate member is configured to be disposed within a kidney of a patient. The second portion of the elongate member, which has a sidewall that defines a lumen, is configured to deliver fluid from a first location of the sidewall of the second portion to a second location of the sidewall of the second portion via capillary action. The second portion of the elongate member is configured to be disposed within at least one of a bladder and a ureter of the patient.

    Abstract translation: 在一些实施例中,输尿管支架包括具有第一部分和第二部分的细长构件,其连接到第一部分。 细长构件的第一部分被配置为设置在患者的肾脏内。 具有限定内腔的侧壁的细长构件的第二部分构造成通过毛细作用将流体从第二部分的侧壁的第一位置输送到第二部分的侧壁的第二位置。 细长构件的第二部分构造成设置在患者的膀胱和输尿管中的至少一个中。

    Occlusion of fallopian tubes in a vertebrate subject
    10.
    发明授权
    Occlusion of fallopian tubes in a vertebrate subject 有权
    在脊椎动物受试者中输卵管阻塞

    公开(公告)号:US08360065B2

    公开(公告)日:2013-01-29

    申请号:US12782958

    申请日:2010-05-19

    CPC classification number: A61F6/225

    Abstract: According to one claim of the invention, a method for occluding a fallopian tube in a vertebrate subject is described, which comprises comprising transcervically delivering a solid blocking material into the fallopian tube. In various embodiments, a fluid sealing material is delivered along with the solid blocking material. Other claims of the invention pertain to articles of manufacture, delivery devices and kits for use in occluding the fallopian tubes of a vertebrate subject.

    Abstract translation: 根据本发明的一个权利要求,描述了一种用于在脊椎动物受试者中闭塞输卵管的方法,其包括将固体阻塞材料递送到输卵管中。 在各种实施例中,流体密封材料与固体阻挡材料一起被输送。 本发明的其它权利要求涉及用于阻塞脊椎动物对象的输卵管的制品,递送装置和试剂盒。

Patent Agency Ranking